• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venmax Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 6161.0
  • ISIN : INE154G01022
29.21 1 (5.00%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    29.00

  • Today’s High

    29.21

  • Open

    29.21

  • Perv Close

    27.82

  • 52W Low

    6.27

  • 52W High

    30.88

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    15.31

  • Div & Yield %

    0.00

  • Book Value(₹)

    -2.74

  • Debt-Equity Ratio

    5.00

  • AGM Date

    29-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    15.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.24

  • BV (₹)

    -2.70

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    0.06

  • NP Var(%)

    -71.0

  • Div%

    0.0

  • CPS (₹)

    0.10

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    15.31

  • 52 Week High

    30.88

  • 52 Week Low

    6.27

  • Price BSE

    29.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    15.31

  • P/C Ratio

    211.90

  • P/E Ratio

    235.60

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.17 0.47 0.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.17 0.47 0.15
Other Income 0.20 0.42 1.98 0.18 0.00 0.00
Stock Adjustments 0.00 0.00 0.00 -0.22 0.11 0.11
Total Income 0.20 0.42 1.98 0.13 0.58 0.26
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.08 0.43 0.20
Power and Fuel Cost 0.00 0.01 0.00 0.00 0.00 0.01
Employee Cost 0.02 0.03 0.01 0.06 0.22 0.10
Other Manufacturing Expenses 0.01 0.00 0.00 0.00 0.00 0.02
Selling and Administration Expenses 0.05 0.10 0.11 0.13 0.17 0.16
Miscellaneous Expenses 0.02 0.04 0.01 0.02 0.02 0.01
Employee Benefit Expenses 0.02 0.03 0.01 0.06 0.22 0.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.10 0.19 0.13 0.29 0.84 0.50
Operating Profit 0.09 0.23 1.86 -0.15 -0.25 -0.23
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.09 0.23 1.86 -0.15 -0.25 -0.23
Depreciation 0.01 0.01 0.01 0.01 0.01 0.01
Profit Before Tax 0.08 0.22 1.85 -0.16 -0.26 -0.24
Current Tax 0.02 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.01 0.00
Reported Net Profit 0.06 0.23 1.85 -0.16 -0.27 -0.24
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.06 0.23 1.85 -0.16 -0.27 -0.24
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.95 -6.18 -8.76 -8.59 -8.32 -8.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.89 -5.95 -6.91 -8.76 -8.59 -8.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.12 0.43 3.52 -0.31 -0.52 -0.45
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value -1.24 -1.36 -1.79 -5.32 -5.01 -4.49
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    23.14%

  • Public Share Holding

    76.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,212,025 23.14 1,020,625 106
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,212,025 23.14 1,020,625 106
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 7,650 0.15 7,650 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,650 0.15 7,650 1
2] Non Institution
Bodies Corporate 301,427 5.75 197,327 44
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 262,950 5.02 2,250 300
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,679,123 32.05 1,329,123 16
Individuals holding nominal share capital up to Rs. 1 lakh 1,738,997 33.19 886,567 6,262
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 36,758 0.70 36,758 27
Sub Total 4,019,255 76.72 2,452,025 6,649
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,238,930 100.00 3,480,300 6,756

Company Background

Venmax Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Venmax Drugs & Pharmaceuticals Ltd
  • BSE Code : 6161.0
  • ISIN : INE154G01022

  • Incorporation Year

    1988

  • Registered Office

    Sy No 115 Brig Sayeed Road
    Hanumanji Colony Old Bowenpall, Secunderabad,
    Telangana-500009

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    N Krishnaniah

  • Company Secretary

    Sandan Grover

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Venmax Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venmax Drugs 29.21 0.20 0.00 -20.57 1.43
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92